Literature DB >> 34403089

Evaluation of Vestibular Function in Diagnosis of Vestibular Schwannomas.

Xue-Qing Zhang1,2,3,4,5, Tai-Sheng Chen1,2,3,4,5, Wei Wang6,7,8,9,10.   

Abstract

Vestibular schwannomas (VS) are benign tumors of the vestibular nerve. The common first symptoms are hearing loss and tinnitus, followed by imbalance, vertigo, and facial nerve involvement. The subjective symptoms of VS patients are not consistent with the severity of vestibular lesions and the results of vestibular tests, which often interfere with clinicians' diagnoses. Thus, the main screening and diagnostic methods for VS are audiometry and magnetic resonance imaging (MRI), ignoring the evaluation of vestibular function at the source of pathological lesions. With the development and improvement of vestibular evaluation technology and its wide application in the clinic, modern vestibular examination technology can reflect the severity and frequency of vestibular lesions and compensation from multiple perspectives, providing an objective basis for the diagnosis and treatment of vestibular diseases. In this report, we review the results and characteristics of vestibular tests in VS patients and further clarify the clinical value of vestibular function assessment in the diagnosis and treatment of VS.
© 2021. Huazhong University of Science and Technology.

Entities:  

Keywords:  vertigo; vestibular compensation; vestibular function test; vestibular schwannomas

Mesh:

Year:  2021        PMID: 34403089     DOI: 10.1007/s11596-021-2407-1

Source DB:  PubMed          Journal:  Curr Med Sci        ISSN: 2523-899X


  49 in total

1.  Clinical picture of vestibular schwannoma.

Authors:  E Kentala; I Pyykkö
Journal:  Auris Nasus Larynx       Date:  2001-01       Impact factor: 1.863

2.  Imaging of hearing loss.

Authors:  Michele B St Martin; Barry E Hirsch
Journal:  Otolaryngol Clin North Am       Date:  2008-02       Impact factor: 3.346

3.  Vestibular schwannomas.

Authors:  Jacques J Morcos
Journal:  J Neurosurg       Date:  2012-11-09       Impact factor: 5.115

4.  An Update on Epidemiology and Management Trends of Vestibular Schwannomas.

Authors:  Vivek C Pandrangi; Albert Y Han; Jose E Alonso; Kevin A Peng; Maie A St John
Journal:  Otol Neurotol       Date:  2020-03       Impact factor: 2.311

5.  The prevalence of "incidental" acoustic neuroma.

Authors:  Doris Lin; Joseph L Hegarty; Nancy J Fischbein; Robert K Jackler
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2005-03

6.  Acoustic neuroma: a cost-effective approach.

Authors:  D B Welling; M E Glasscock; C I Woods; C G Jackson
Journal:  Otolaryngol Head Neck Surg       Date:  1990-09       Impact factor: 3.497

7.  Descriptive epidemiology of vestibular schwannomas.

Authors:  Jennifer M Propp; Bridget J McCarthy; Faith G Davis; Susan Preston-Martin
Journal:  Neuro Oncol       Date:  2006-01       Impact factor: 12.300

8.  Predictors of vertigo in patients with untreated vestibular schwannoma.

Authors:  Jan Fredrik Andersen; Kathrin Skorpa Nilsen; Flemming Slinning Vassbotn; Per Møller; Erling Myrseth; Morten Lund-Johansen; Frederik Kragerud Goplen
Journal:  Otol Neurotol       Date:  2015-04       Impact factor: 2.311

9.  EANO guideline on the diagnosis and treatment of vestibular schwannoma.

Authors:  Roland Goldbrunner; Michael Weller; Jean Regis; Morten Lund-Johansen; Pantelis Stavrinou; David Reuss; D Gareth Evans; Florence Lefranc; Kita Sallabanda; Andrea Falini; Patrick Axon; Olivier Sterkers; Laura Fariselli; Wolfgang Wick; Joerg-Christian Tonn
Journal:  Neuro Oncol       Date:  2020-01-11       Impact factor: 12.300

10.  Relationship of Vertigo and Postural Instability in Patients With Vestibular Schwannoma.

Authors:  Gi-Sung Nam; Chan Min Jung; Ji Hyung Kim; Eun Jin Son
Journal:  Clin Exp Otorhinolaryngol       Date:  2018-01-09       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.